Omid Mirmosayyeb, MD

Процитировано

	Все	Начиная с 2019 г.
Статистика цитирования	1660	1602
h-индекс	19	19
i10-индекс	52	51

540

270

135

405

2016201720182019202020212022202320247 7 27 50 147 231 396 540 223

Общий доступ

Просмотреть все

2 статьи

доступно

недоступно

На основе финансирования

Соавторы

Vahid ShaygannejadDepartment of Neurology, Isfahan university of medical sciencesПодтвержден адрес электронной почты в домене med.mui.ac.ir
AliReza Afshari SafaviNorth Khorasan University of Medical ScienceПодтвержден адрес электронной почты в домене nkums.ac.ir
Nasim NehzatPharmacyПодтвержден адрес электронной почты в домене buffalo.edu
Saeed VahebIsfahan Neurosciences Research Center, Isfahan University of medical sciencesПодтвержден адрес электронной почты в домене res.mui.ac.ir
Shervin BadihianCleveland ClinicПодтвержден адрес электронной почты в домене ccf.org
Elham Moases GhaffaryPharmacy School, University of Missouri-Kansas CityПодтвержден адрес электронной почты в домене umkc.edu
Serge BrandUniversity of Basel, Basel, SwitzerlandПодтвержден адрес электронной почты в домене upk.ch
Hamed GhoshouniMD-MPHПодтвержден адрес электронной почты в домене stu.ssu.ac.ir
Fardin NabizadehResearcher at Iran University of Medical ScienceПодтвержден адрес электронной почты в домене iums.ac.ir
A. Hadi Maghzi, M.D.Brigham and Women's Hospital, Harvard Medical SchoolПодтвержден адрес электронной почты в домене bwh.harvard.edu
Mohammad Yazdan PanahSchool of Medicine, Shahrekord University of Medical Science, Shahrekord, IranПодтвержден адрес электронной почты в домене skums.ac.ir
Dejan JakimovskiDepartment of Neurology, Jacobs School of Medicine and Biomedical Sciences, University of BuffaloПодтвержден адрес электронной почты в домене bnac.net
Amirreza ManteghinejadDepartment of Radiology, Children's Hospital of PhiladelphiaПодтвержден адрес электронной почты в домене chop.edu
Mona AsghariahmadabadNeurological Surgery Postdoctoral Scholar at University of California San FranciscoПодтвержден адрес электронной почты в домене ucsf.edu
Farhad MahmoudiPostdoctoral Associate, University of PittsburghПодтвержден адрес электронной почты в домене pitt.edu
Mahdi Barzegar (Barzegareskandarko...Isfahan neurosciences research center; Medical doctor

Omid Mirmosayyeb, MD

Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University of Buffalo

Подтвержден адрес электронной почты в домене buffalo.edu - Главная страница

Multiple Sclerosis Neuromyelitis Optica Cognition Systematic Review


Название По числу цитат По году По названию	Процитировано Процитировано	Год
COVID-19 among patients with multiple sclerosis: a systematic review M Barzegar, O Mirmosayyeb, M Gajarzadeh, A Afshari-Safavi, N Nehzat, ... Neurology: Neuroimmunology & Neuroinflammation 8 (4), e1001, 2021	89	2021
COVID-19 infection in a patient with multiple sclerosis treated with fingolimod M Barzegar, O Mirmosayyeb, N Nehzat, R Sarrafi, F Khorvash, AH Maghzi, ... Neurology: Neuroimmunology & Neuroinflammation 7 (4), e753, 2020	82	2020
Clinical characteristics and disability progression of early-and late-onset multiple sclerosis compared to adult-onset multiple sclerosis O Mirmosayyeb, S Brand, M Barzegar, A Afshari-Safavi, N Nehzat, ... Journal of clinical medicine 9 (5), 1326, 2020	77	2020
Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study M Barzegar, S Vaheb, O Mirmosayyeb, A Afshari-Safavi, N Nehzat, ... Multiple sclerosis and related disorders 52, 102947, 2021	59	2021
Efficacy and safety of rituximab in neuromyelitis optica: review of evidence M Etemadifar, M Salari, O Mirmosayyeb, M Serati, R Nikkhah, M Askari, ... Journal of Research in Medical Sciences 22 (1), 18, 2017	57	2017
Comparative study of quality of life, anxiety, depression, and fatigue among patients with neuromyelitis optica spectrum disorder and multiple sclerosis: the first report from Iran M Barzegar, S Badihian, O Mirmosayyeb, F Ashtari, M Jamadi, S Emami, ... Multiple sclerosis and related disorders 22, 161-165, 2018	56	2018
Possible role of common spices as a preventive and therapeutic agent for Alzheimer's disease O Mirmosayyeb, A Tanhaei, HR Sohrabi, RN Martins, M Tanhaei, ... International journal of preventive medicine 8, 2017	49	2017
Prevalence of multiple sclerosis (MS) in Iran: a systematic review and meta-analysis O Mirmosayyeb, V Shaygannejad, S Bagherieh, AM Hosseinabadi, ... Neurological Sciences 43, 233-241, 2022	48	2022
The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis AN Moghadasi, O Mirmosayyeb, M Barzegar, MA Sahraian, ... Neurological sciences 42 (8), 3093-3099, 2021	45	2021
An 8-year study of people with multiple sclerosis in Isfahan, Iran: Association between environmental air pollutants and severity of disease F Ashtari, N Esmaeil, M Mansourian, P Poursafa, O Mirmosayyeb, ... Journal of neuroimmunology 319, 106-111, 2018	42	2018
Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic M Ghajarzadeh, O Mirmosayyeb, M Barzegar, N Nehzat, S Vaheb, ... Multiple Sclerosis and Related Disorders 43, 102222, 2020	35	2020
Characteristics of COVID-19 disease in multiple sclerosis patients M Barzegar, O Mirmosayyeb, M Ghajarzadeh, N Nehzat, S Vaheb, ... Multiple Sclerosis and Related Disorders 45, 102276, 2020	33	2020
A short review on structure and role of cyclic-3’, 5’-adenosine monophosphate-specific phosphodiesterase 4 as a treatment tool N Eskandari, O Mirmosayyeb, G Bordbari, R Bastan, Z Yousefi, A Andalib Journal of research in pharmacy practice 4 (4), 175-181, 2015	32	2015
Long-term tolerability, safety and efficacy of rituximab in neuromyelitis optica spectrum disorder: a prospective study V Shaygannejad, E Fayyazi, S Badihian, O Mirmosayyeb, N Manouchehri, ... Journal of Neurology 266, 642-650, 2019	31	2019
Early predictors of conversion to secondary progressive multiple sclerosis M Barzegar, S Najdaghi, A Afshari-Safavi, N Nehzat, O Mirmosayyeb, ... Multiple sclerosis and related disorders 54, 103115, 2021	30	2021
The prevalence of migraine in multiple sclerosis (MS): A systematic review and meta-analysis O Mirmosayyeb, M Barzegar, N Nehzat, V Shaygannejad, MA Sahraian, ... Journal of Clinical Neuroscience 79, 33-38, 2020	27	2020
Evaluation of non-motor symptoms and their impact on quality of life in patients with Parkinson’s disease, Isfahan, Iran M Salari, A Chitsaz, M Etemadifar, MR Najafi, O Mirmosayyeb, ... Iranian journal of neurology 16 (3), 118, 2017	26	2017
Parkinson’s disease and COVID-19: A systematic review and meta-analysis RJ Khoshnood, A Zali, A Tafreshinejad, M Ghajarzadeh, N Ebrahimi, ... Neurological Sciences, 1-9, 2022	23	2022
COVID-19 susceptibility and outcomes among patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis M Barzegar, O Mirmosayyeb, N Ebrahimi, S Bagherieh, A Afshari-Safavi, ... Multiple Sclerosis and Related Disorders 57, 103359, 2022	20	2022
Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: a systematic review O Mirmosayyeb, EM Ghaffary, S Vaheb, R Pourkazemi, V Shaygannejad Revue Neurologique 179 (4), 265-281, 2023	19	2023

В данный момент система не может выполнить эту операцию. Повторите попытку позднее.

Статьи 1–20

Ссылок за год

Повторяющиеся цитирования

Объединенные цитирования

СоавторыСоавторы

Подписаться

Процитировано

Соавторы